Together, MEF2C dysregulation by the enhancer mutation leads to mitochondrial dysfunction and oxidative stress, which are prevalent features in motor neuronal damage and ALS pathogenesis. This evidence concerns the gene MEF2C and amyotrophic lateral sclerosis.